ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
64,023.11
0.20%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PureTech Health PLC (PRTC) Quote

PureTech Health PLC

PureTech Health PLC (PRTC)

Puretech Health Plc
28.4708
0.5008
(1.79%)
Closed May 04 4:00PM
Delayed by 15 minutes
28.4708
0.00
(0.00%)
After Hours: 4:00PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
28.4708
Bid
11.20
Ask
65.00
Volume
294
27.69 Day's Range 28.4708
0.00 52 Week Range 0.00
Market Cap
610.06M
Previous Close
27.97
Open
28.07
Last Trade
1
@
27.29
Last Trade Time
Financial Volume
$ 8,370
VWAP
28.4708
Average Volume (3m)
-
Shares Outstanding
278,566,000
Dividend Yield
-
PE Ratio
-12.11
Earnings Per Share (EPS)
-0.18
Revenue
23.75M
Net Profit
-50.35M

About PureTech Health PLC

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines ... PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, neurological & neuropsychological disorders, among others. It operates in following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of society's healthcare needs. Show more

Sector
Home Health Care Services
Industry
Home Health Care Services
Website
www.puretechhealth.com
Headquarters
London, Gbr
Founded
1970
PureTech Health PLC is listed in the Home Health Care Services sector of the NASDAQ with ticker PRTC. The last closing price for PureTech Health was $27.97. Over the last year, PureTech Health shares have traded in a share price range of $ 0.00 to $ 0.00.

PureTech Health currently has 278,566,000 shares outstanding. The market capitalization of PureTech Health is $610.06 million. PureTech Health has a price to earnings ratio (PE ratio) of -12.11.

PRTC Latest News

More News

PureTech Announces Annual Results for Year Ended December 31, 2023

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...

April 25 2024
Business Wire

PureTech Health: Notice of Results

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on...

April 18 2024
Business Wire

PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis

Topline results are expected in Q4 2024 PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of...

April 16 2024
Business Wire

PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers

LYT-200 is being evaluated in locally advanced/metastatic solid tumors, including head and neck cancers, as well as in hematological malignancies, such as acute myeloid leukemia and high-risk...

April 11 2024
Business Wire

PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions

Bharatt Chowrira, Ph.D., J.D., named Chief Executive Officer of PureTech; PureTech Co-founder, Eric Elenko, Ph.D., promoted to President PureTech Founding Chief Executive Officer, Daphne Zohar...

April 09 2024
Business Wire

PureTech Proposes $100 Million Capital Return

Proposed capital return of $100 million by way of a Tender Offer at 250 pence per Ordinary Share Premium of 25% to PureTech’s trailing three-day VWAP Proposed Tender Offer follows completion of...

March 19 2024
Business Wire

Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion

Acquisition centered on KarXT, which was invented at PureTech, as a potential first-in-class treatment for schizophrenia in adults PureTech to receive approximately $293 million gross proceeds...

March 18 2024
Business Wire

PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia

LYT-200 is being advanced in hematological malignancies such as acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS), and locally advanced/metastatic solid tumors, including...

March 13 2024
Business Wire

PureTech to Present at Two Upcoming Investor Conferences

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...

February 27 2024
Business Wire

PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan

Japanese Product Now Under Review for Nationwide Marketing Approval PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated...

February 27 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
Nihil8 Nihil8 2 minutes ago
I can explain away a couple things but not a combination of:

1) Us being in EM after they assured us we wouldn’t be.

2) The company strongly implying on Twitter last summer that they hired Rhonda to get us out of EM, but soon after issuing a retraction after people call
CNNA
moondogaz moondogaz 3 minutes ago
Hope u took profit off table..smlt.
BEGI
uber darthium uber darthium 4 minutes ago
Do I need to make you my girl again ? Have you missed me that much sweetheart ?
delerious1 delerious1 4 minutes ago
Too bad so much hostility on a good bet
IGPK
Timing101 Timing101 5 minutes ago
$DUTV Also , see the share structure is NOW showing the reduction of the CANCELED shares . That Means the other Billions of Common shares issued and Preferred shares issued are just around the Corner to SHOWING. Once they show it will take HUGE (millions of shares traded daily to move this Sy
DUTV
Hercules1 Hercules1 6 minutes ago
https://twitter.com/jctb1/status/1786799538436796788
AGBA
moviesam moviesam 7 minutes ago
We know HHSE is the worthless outhouse ticker you are invested in... Please tell us the name of the billion dollar company "you're" invested in.

I'm an investor in a future billion dollar company, I have my thoughts on why your here.
HHSE
crazy horse 0 crazy horse 0 7 minutes ago
This is me anyone else here

https://www.youtube.com/watch?v=G_SXJ18EkNw
JPetroInc JPetroInc 8 minutes ago
yup got one

was just looking to see if a link had been established for the call..

which would work toward getting the word out...!

MONI
MONI
TradingCharts TradingCharts 8 minutes ago
Wow interesting for sure.
Leveraging this principle, Dr. Hlova’s team developed MELLT. This process involves placing solid spodumene chunks and a solid reactant chemical, such as sodium carbonate (Na2CO3), into a chamber with steel balls. The chamber undergoes various movements, subjecting th
Shekiboy Shekiboy 10 minutes ago
You and the other idiot pumpers don't know what Karma is.

But with this fraudulent trash scam you are about to find out in a most concerning way.


As they say, 'Karma is a bitch'...


The hurt is coming.
SPZI
jmoney360 jmoney360 10 minutes ago
GO RNVA 🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑
RNVA
Timing101 Timing101 11 minutes ago
Or just how much CC , GC and JC dispise how Harry Z has handled things . Bottom line it was Harry's time to let go some and let others do some things and move forward. Harry kept pushing buttons it appears with others involved, the ATM with shares kept rolling from Harry Z pin code and here is t
ENZC
TradingCharts TradingCharts 11 minutes ago
If/when you have time watch this podcast.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174358232
moondogaz moondogaz 12 minutes ago
Liked " zero share increase"ty..I added too.
BEGI
RIOgrande44 RIOgrande44 13 minutes ago
Getting revoked has nothing to do with taking a company private, absolutely nothing.
Your weekend response time to discredit a post is however impressive.
crazy horse 0 crazy horse 0 13 minutes ago
This is most of the BOARD BABY BOOMERS (1946 - 1964)

https://scontent-atl3-2.xx.fbcdn.net/v/t39.30808-6/441389213_7691622250859968_8013823415494673437_n.jpg?_nc_cat=105&ccb=1-7&_nc_sid=5f2048&_nc_ohc=X88EarKimP0Q7kNvgHN9PMV&_nc_ht=scontent-atl3-2.xx&oh=00_AfAR9y39cm-h6viw2TVrK-lUKP3P
4u2nv2 4u2nv2 15 minutes ago
Let's start by getting to a penny or maybe telling the class what our true intentions are here? But I think we know that already. It's up to a random poster that is talking about MCIC just for entertainment purposes to fall into that trap? Try again. All of our posts are strictly for entertainment p
MCIC
michael702/ michael702/ 16 minutes ago
Patience will be rewarded with this company in my opinion!
BLLB

Your Recent History

NASDAQ
PRTC
PureTech Health
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved